Cite
miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.
MLA
Gebeshuber, C. A., and J. Martinez. “MiR-100 Suppresses IGF2 and Inhibits Breast Tumorigenesis by Interfering with Proliferation and Survival Signaling.” Oncogene, vol. 32, no. 27, July 2013, pp. 3306–10. EBSCOhost, https://doi.org/10.1038/onc.2012.372.
APA
Gebeshuber, C. A., & Martinez, J. (2013). miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. Oncogene, 32(27), 3306–3310. https://doi.org/10.1038/onc.2012.372
Chicago
Gebeshuber, C A, and J Martinez. 2013. “MiR-100 Suppresses IGF2 and Inhibits Breast Tumorigenesis by Interfering with Proliferation and Survival Signaling.” Oncogene 32 (27): 3306–10. doi:10.1038/onc.2012.372.